Join a newly formed, modern team inside our Agile Release Train - a small squad working next to five established engineering teams, but set up differently. Instead of passing work down a chain (analyst → designer → developer → tester → devops), the team owns each feature end-to-end and everyone works on it at the same time. Design decisions are tested as they're made, and quality is built in as the code is written.
The result is a much shorter path from problem to finished, releasable product.
This role is for someone who wants full ownership, solves problems from the ground up, and is excited to use AI and automation to cut out steps - not just speed them up. You'll work on regulated medical device software that changes the lives of people living with hearing loss.
What we offer:
What awaits you?
What you need to have?
Skills you'll keep building:
We're looking for someone who can become a full SWE and has the drive to get there. The hard skills above follow from that drive rather than gate entry to the role - a strong SWE keeps building this range over time, and the appetite to do so matters more than having all of it on day one.
Nice to have:
#LI-AL1#LI-HYBRID#Demant_Poland

Demant is a world-leading hearing healthcare group built on a heritage of care, health and innovation since 1904. The Group offers solutions and services to help people connect and communicate with the world around them. For more than a century, the Demant Group has played a vital part in developing innovative technologies and gathering know-how to help improve people’s hearing and health. In every aspect, from providing hearing care to delivering hearing aids and diagnostic equipment and services to hearing care professionals and users all over the world, Demant is active and engaged.
The Demant Group operates in a global market with subsidiaries in more than 30 countries, employs more than 22,000 employees and generates annual revenue of more than DKK 22 billion. Our products are sold in more than 130 countries where we create life-changing differences through hearing health.
Listed on Nasdaq Copenhagen stock exchange as a blue chip stock, Demant is the parent company behind world-renowned and commercially successful brands as Oticon, Bernafon, Sonic, Philips Hearing Solutions, Audika, MAICO, Interacoustics, Amplivox, Grason-Stadler, MedRx and Audioscan. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.
If you want to know how we process your personal data on social media platforms, visit this site: https://www.demant.com/privacy-notice#some